On the other hand, during an insulin tolerance test, the two MSG-treated groups had a significantly reduced response to the hypoglycaemic effects of insulin, when compared with P-P and P-7 groups (p<0.05) (Figure 1D), indicating a state of insulin resistance.
First, 84% of our blood donors, but only 66% of the HIV patients (p = 0.003), responded to at least one of the three Msg fragments.
Twenty-two MSG-reactors, who suffered from any symptoms in the first study, formed test groups in the second study and were administered 1 5 g MSG dissolved in 150 ml tomato juice or water.
Three MSGs were developed and played by teams of four students in order to solve problems collaboratively.
Ten MSGs obtained from subjects with sicca symptoms, but without any clinical and serological features of pSS, acted as controls (five normal MSGs and five showing different grades of nonspecific chronic sialadenitis (NSCS), without FLS).
The factors in the ANOVA were session (two levels: MSG and placebo), type of the injections (two levels: Glu and IS), time (BL, 15 min after the oral intervention, 5 min and 10 min after the injection, and the Post).
For analysis of Glu concentration in the saliva samples, a two-way ANOVA was used with session (two levels: MSG and placebo) and time (six levels: Baseline, 30, 45, 60, 75 min after the systemic intervention, and the Post) as main factors.
Fifteen pSS MSGs, collected at the time of diagnosis, were also retrospectively evaluated.
Five normal MSGs of subjects with sicca symptoms and an absence of any clinical and serological feature of pSS were used as controls.
We studied 12 SS-mSGs, four SS-MSGs with lympho-epithelial lesion and 20 SS-MSGs with non-Hodgkin B-cell MALT-Ls.
